The World Health Organization's latest guideline on risk reduction of cognitive decline and dementia has been published. This guideline provides global, evidence-informed recommendations on how to reduce the risk of cognitive decline and dementia.
It features evidence from reviews of the Cochrane Dementia and Cognitive Improvement group in 3 of the guideline’s evidence profiles - Physical activity interventions, Management of diabetes and Management of dyslipidaemia. The featured reviews are:
- Aerobic exercise to improve cognitive function in older people without known cognitive impairment
- Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia
- Statins for the prevention of dementia
Cochrane Dementia and Cognitive Improvement remit includes producing systematic reviews of both global cognitive impairment and focal cognitive impairments occurring in the context of brain disease. We are pleased to see Cochrane evidence being highlighted in this important guideline.
